|
Feb 21
|
Zealand Pharma AS (ZLDPF) Q4 2024 Earnings Call Highlights: Strong Cash Position and Obesity ...
|
|
Feb 20
|
Zealand Pharma steadfastly upholds amylin-based obesity drug strategy
|
|
Feb 20
|
Zealand Pharma convenes its Annual General Meeting 2025
|
|
Feb 20
|
Correction: Zealand Pharma Announces Financial Results for the Full Year 2024
|
|
Feb 20
|
Zealand Pharma Announces Financial Results for the Full Year 2024
|